Shire, Maker of Binge-Eating Drug Vyvanse, First Marketed the Disease

Tuesday, February 24, 2015 - 23:50 in Health & Medicine

The strategy for a new drug to treat binge-eating disorder reveals how a pharmaceutical company can influence the treatment of a medical condition.

Read the whole article on NY Times Science

More from NY Times Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net